These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
5. Two Li-Fraumeni syndrome families with novel germline p53 mutations: loss of the wild-type p53 allele in only 50% of tumours. Sedlacek Z; Kodet R; Kriz V; Seemanova E; Vodvarka P; Wilgenbus P; Mares J; Poustka A; Goetz P Br J Cancer; 1998 Apr; 77(7):1034-9. PubMed ID: 9569035 [TBL] [Abstract][Full Text] [Related]
6. Analysis of genomic instability in Li-Fraumeni fibroblasts with germline p53 mutations. Liu PK; Kraus E; Wu TA; Strong LC; Tainsky MA Oncogene; 1996 Jun; 12(11):2267-78. PubMed ID: 8649766 [TBL] [Abstract][Full Text] [Related]
7. p53, CHK2, and CHK1 genes in Finnish families with Li-Fraumeni syndrome: further evidence of CHK2 in inherited cancer predisposition. Vahteristo P; Tamminen A; Karvinen P; Eerola H; Eklund C; Aaltonen LA; Blomqvist C; Aittomäki K; Nevanlinna H Cancer Res; 2001 Aug; 61(15):5718-22. PubMed ID: 11479205 [TBL] [Abstract][Full Text] [Related]
8. Li-Fraumeni and Li-Fraumeni-like syndrome among children diagnosed with pediatric cancer in Southern Brazil. Giacomazzi J; Selistre SG; Rossi C; Alemar B; Santos-Silva P; Pereira FS; Netto CB; Cossio SL; Roth DE; Brunetto AL; Zagonel-Oliveira M; Martel-Planche G; Goldim JR; Hainaut P; Camey SA; Ashton-Prolla P Cancer; 2013 Dec; 119(24):4341-9. PubMed ID: 24122735 [TBL] [Abstract][Full Text] [Related]
9. Detection of novel germ-line p53 mutations in diverse-cancer-prone families identified by selecting patients with childhood adrenocortical carcinoma. Sameshima Y; Tsunematsu Y; Watanabe S; Tsukamoto T; Kawa-ha K; Hirata Y; Mizoguchi H; Sugimura T; Terada M; Yokota J J Natl Cancer Inst; 1992 May; 84(9):703-7. PubMed ID: 1569604 [TBL] [Abstract][Full Text] [Related]
10. Exclusion of a p53 germline mutation in a classic Li-Fraumeni syndrome family. Evans SC; Mims B; McMasters KM; Foster CJ; deAndrade M; Amos CI; Strong LC; Lozano G Hum Genet; 1998 Jun; 102(6):681-6. PubMed ID: 9703430 [TBL] [Abstract][Full Text] [Related]
11. A germ line mutation in exon 5 of the p53 gene in an extended cancer family. Law JC; Strong LC; Chidambaram A; Ferrell RE Cancer Res; 1991 Dec; 51(23 Pt 1):6385-7. PubMed ID: 1933902 [TBL] [Abstract][Full Text] [Related]
12. Li-Fraumeni and related syndromes: correlation between tumor type, family structure, and TP53 genotype. Olivier M; Goldgar DE; Sodha N; Ohgaki H; Kleihues P; Hainaut P; Eeles RA Cancer Res; 2003 Oct; 63(20):6643-50. PubMed ID: 14583457 [TBL] [Abstract][Full Text] [Related]
13. Absence of germline mutations in exons 5-9 of the p53 gene in patients with Li-Fraumeni-like (SBLA) and familial adenomatous polyposis heritable cancer syndromes. Moore SK; Zambrano N; Lynch HT; Lipkin M; Kopelovich L Cancer Genet Cytogenet; 1996 Sep; 90(2):125-9. PubMed ID: 8830720 [TBL] [Abstract][Full Text] [Related]
14. Beyond Li Fraumeni Syndrome: clinical characteristics of families with p53 germline mutations. Gonzalez KD; Noltner KA; Buzin CH; Gu D; Wen-Fong CY; Nguyen VQ; Han JH; Lowstuter K; Longmate J; Sommer SS; Weitzel JN J Clin Oncol; 2009 Mar; 27(8):1250-6. PubMed ID: 19204208 [TBL] [Abstract][Full Text] [Related]
15. Pediatric cancer and Li-Fraumeni/Li-Fraumeni-like syndromes: a review for the pediatrician. Giacomazzi CR; Giacomazzi J; Netto CB; Santos-Silva P; Selistre SG; Maia AL; Oliveira VZ; Camey SA; Goldim JR; Ashton-Prolla P Rev Assoc Med Bras (1992); 2015; 61(3):282-9. PubMed ID: 26248253 [TBL] [Abstract][Full Text] [Related]
16. The TP53 mutational spectrum and frequency of CHEK2*1100delC in Li-Fraumeni-like kindreds. Siddiqui R; Onel K; Facio F; Nafa K; Diaz LR; Kauff N; Huang H; Robson M; Ellis N; Offit K Fam Cancer; 2005; 4(2):177-81. PubMed ID: 15951970 [TBL] [Abstract][Full Text] [Related]